JCLCX
Price
$12.35
Change
-$0.03 (-0.24%)
Updated
Oct 9 closing price
Net Assets
1.58B
VASIX
Price
$15.89
Change
-$0.03 (-0.19%)
Updated
Oct 9 closing price
Net Assets
4.01B
Interact to see
Advertisement

JCLCX vs VASIX

Header iconJCLCX vs VASIX Comparison
Open Charts JCLCX vs VASIXBanner chart's image
JHancock Multimanager Lifestyle Cnsrv C
Price$12.35
Change-$0.03 (-0.24%)
VolumeN/A
Net Assets1.58B
Vanguard LifeStrategy Income I
Price$15.89
Change-$0.03 (-0.19%)
VolumeN/A
Net Assets4.01B
JCLCX vs VASIX Comparison Chart in %
View a ticker or compare two or three
VS
JCLCX vs. VASIX commentary
Oct 11, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JCLCX is a Hold and VASIX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VASIX has more cash in the bank: 4.01B vs. JCLCX (1.58B). VASIX pays higher dividends than JCLCX: VASIX (3.50) vs JCLCX (2.97). JCLCX was incepted earlier than VASIX: JCLCX (20 years) vs VASIX (31 years). JCLCX (1.93) is less costly to investors than VASIX (0.11). JCLCX is a more actively managed with annual turnover of: 16.00 vs. VASIX (5.00). JCLCX has a lower initial minimum investment than VASIX: JCLCX (1000) vs VASIX (3000). JCLCX annual gain was more profitable for investors over the last year : 6.18 vs. VASIX (4.74). JCLCX return over 5 years is better than : 5.94 vs. VASIX (5.17).
JCLCXVASIXJCLCX / VASIX
Total Expense Ratio1.930.111,755%
Annual Report Gross Expense Ratio1.930.111,755%
Fund Existence20 years31 years-
Gain YTD7.4008.18390%
Front LoadN/AN/A-
Min. Initial Investment1000300033%
Min. Initial Investment IRA1000N/A-
Net Assets1.58B4.01B39%
Annual Yield % from dividends2.973.5085%
Returns for 1 year6.184.74130%
Returns for 3 years22.6523.7695%
Returns for 5 years5.945.17115%
Returns for 10 years18.8132.9957%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
EUXTF149.400.65
+0.44%
Euronext NV
CLVLF8.60N/A
N/A
Clinuvel Pharmaceuticals Ltd.
EBRPF21.00N/A
N/A
Ebro Foods SA
CYDX0.27N/A
N/A
CYduct Diagnostics Inc.
LQWDF1.27-0.04
-3.13%
LQWD TECHNOLOGIES CORP.